After a long rally, major consolidation happened in this stock. Now tested at higher prices but volume is not impressive to enter into stock so, no reason to buy for new buyers(they will wait for proper correction) unless any good news for pharma or stock the price struggles to move further. My view is neutral to short. It breaks the support and again raising to...
